Professor of Ophthalmology
farrokh.farzad@invitrovo.com
Cumulative Release Profile
As illustrated in Figure 1, the release curve demonstrates the gradual, controlled release of CsA over time, maintaining concentrations within the therapeutic window and avoiding peaks that may cause toxicity or valleys that result in sub-therapeutic exposure.
Proof-of-Concept Clinical study
A pilot clinical trial demonstrated the effective placement and retention of FORNISERT in the conjunctival fornix. Key visual references include (Figure2):
Have questions about our lab services or research capabilities?
Connect with our experts for tailored guidance and technical insight.
